• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    RayzeBio, Inc. - Common Stock (NQ: RYZB )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Feb 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about RayzeBio, Inc. - Common Stock

    Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
    From Bristol Myers Squibb
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay Therapeutics, Inc. (Nasdaq – CBAY), Masonite International Corporation (NYSE – DOOR), ZeroFox Holdings, Inc. (Nasdaq – ZFOX), RayzeBio, Inc. (Nasdaq – RYZB)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period
    From Bristol Myers Squibb
    Via Business Wire
    Pancreatic Cancer Treatments Poised for Major Advances in 2024
    EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INCY),(NASDAQ:TNGX),(NASDAQ:RYZB),(NYSE:BMY) EQNX::TICKER_END 
    Via FinancialNewsMedia
    IPO watch 2024: Which new stocks will hit the market?
    Expectations are high for the 2024 IPO market, with Reddit, Databricks, and Shein debuts anticipated, hinting at a substantial influx of new public companies. 
    Via MarketBeat
    Topics Initial Public Offering
    Exposures Securities Market
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    RAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals
    Bristol Myers announced two acquisitions in a week. The pharma giant is boosting its neuroscience pipeline with Karuna and its oncology pipeline with RayzeBio. 
    Via MarketBeat
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    RYZB Stock Alert: Halper Sadeh LLC Is Investigating RayzeBio, Inc.
    From Halper Sadeh LLC
    Via Business Wire
    Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
    From Rayzebio, Inc.
    Via GlobeNewswire
    Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
    From Bristol Myers Squibb
    Via Business Wire
    RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    From Rayzebio, Inc.
    Via GlobeNewswire
    RayzeBio to Participate in Upcoming Investor Conferences in November 2023
    From Rayzebio, Inc.
    Via GlobeNewswire
    RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors
    From Rayzebio, Inc.
    Via GlobeNewswire
    FDA selects RayzeBio to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for RYZ101 in GEP-NETs
    From Rayzebio, Inc.
    Via GlobeNewswire
    RayzeBio to Present at European Society for Medical Oncology (ESMO) Congress
    From Rayzebio, Inc.
    Via GlobeNewswire
    RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From RayzeBio, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.